This gene encodes two distinct proteins, p16/INK4A and p14/ARF, which act as tumor suppressors through the negative regulation of pathways involving Rb1 (retinoblastoma protein 1) and p53, respectively [16]. The gene discussed is CDKN2A; the disease is neoplasm.